Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PLC Diagnostics
AddedFeb 18, 2024
UpdatedJun 18, 2026
PLC Diagnostics

PLC Diagnostics

Angel

PLC Diagnostics: Innovating molecular biomarker detection for diverse applications since 2006.

HQ
Thousand Oaks, CA, US
Founded
2006
Overview
Compare
Fundraising
Employees

PLC Diagnostics, Inc. develops a diagnostic testing platform for the detection of molecular biomarkers.

Its products are used in various applications, such as infectious diseases diagnosis, targeted DNA re-sequencing, gene-expression panels, pathogens and toxins screening, human identification, and proteomics. PLC Diagnostics, Inc. was incorporated in 2006 and is based in Westlake Village, California.

PLC Diagnostics - Similar Companies

Plasmonic Diagnostics logo

Plasmonic Diagnostics

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Gregor Diagnostics logo

Gregor Diagnostics

Molecular Detection logo

Molecular Detection

Instadiagnostics logo

Instadiagnostics

FYR Diagnostics logo

FYR Diagnostics

fyrdiagnostics.com

NAT Diagnostics logo

NAT Diagnostics

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

Eclipse Diagnostics logo

Eclipse Diagnostics

Smart Diagnostics Systems logo

Smart Diagnostics Systems

Empowered Diagnostics logo

Empowered Diagnostics

Test Diagnostics logo

Test Diagnostics

Co-Diagnostics logo

Co-Diagnostics

co-dx.com

Accelevir Diagnostics logo

Accelevir Diagnostics

Pearl Diagnostics logo

Pearl Diagnostics

pearldx.com

PLC Diagnostics - Quick Facts

Who are PLC Diagnostics' competitors?

Companies similar to PLC Diagnostics include Plasmonic Diagnostics, Prompt Diagnostics, Gregor Diagnostics and Molecular Detection.

When was PLC Diagnostics founded?

PLC Diagnostics was founded in 2006.

Where is PLC Diagnostics' headquarters located?

PLC Diagnostics' headquarters is located in Thousand Oaks, CA, US.

When was PLC Diagnostics' last funding round?

PLC Diagnostics' most recent funding round was for $128.7k (USD) in April 2011.

How much has PLC Diagnostics raised to-date?

As of Apr 11, 2011, PLC Diagnostics has raised a total of $183.7k (USD).

How many employees does PLC Diagnostics have?

PLC Diagnostics has 14 employees as of Feb 5, 2024.

PLC Diagnostics - Classification

Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostic Testing
Tags
  • Biotech
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 8690Other human health activities
Show 11 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified